Health Discovery Corporation (HDVY)
USD 0.0
(-90.0%)
USD 0.0
(-90.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | 100.0% |
| 2020 | -705 Thousand USD | 66.36% |
| 2019 | -2.09 Million USD | -614.93% |
| 2018 | 406.99 Thousand USD | 209.6% |
| 2017 | 131.45 Thousand USD | 418.68% |
| 2016 | -41.25 Thousand USD | 90.11% |
| 2015 | -417.2 Thousand USD | -5359.41% |
| 2014 | -7642.00 USD | 89.38% |
| 2013 | -71.99 Thousand USD | 58.0% |
| 2012 | -171.42 Thousand USD | 80.75% |
| 2011 | -890.32 Thousand USD | 72.98% |
| 2010 | -3.29 Million USD | -41.51% |
| 2009 | -2.32 Million USD | -614.64% |
| 2008 | -325.88 Thousand USD | 80.23% |
| 2007 | -1.64 Million USD | -293.59% |
| 2006 | 851.52 Thousand USD | 188.49% |
| 2005 | 295.16 Thousand USD | -83.92% |
| 2004 | 1.83 Million USD | 333.48% |
| 2003 | 423.41 Thousand USD | 536063.29% |
| 2002 | -79.00 USD | -103.44% |
| 2001 | 2294.00 USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q2 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2021 FY | - USD | 100.0% |
| 2021 Q1 | -519 Thousand USD | 26.38% |
| 2021 Q2 | -273 Thousand USD | 47.4% |
| 2021 Q3 | -58 Thousand USD | 78.75% |
| 2020 Q3 | -1.06 Million USD | 26.28% |
| 2020 FY | -705 Thousand USD | 66.36% |
| 2020 Q1 | -2.15 Million USD | -2.88% |
| 2020 Q2 | -1.45 Million USD | 32.75% |
| 2020 Q4 | -705 Thousand USD | 34.05% |
| 2019 Q1 | 509.78 Thousand USD | 25.26% |
| 2019 Q3 | -1.96 Million USD | 7.8% |
| 2019 FY | -2.09 Million USD | -614.93% |
| 2019 Q2 | -2.13 Million USD | -518.99% |
| 2019 Q4 | -2.09 Million USD | -6.42% |
| 2018 Q2 | 290.05 Thousand USD | 38.82% |
| 2018 FY | 406.99 Thousand USD | 209.6% |
| 2018 Q4 | 406.99 Thousand USD | 14.71% |
| 2018 Q3 | 354.81 Thousand USD | 22.33% |
| 2018 Q1 | 208.94 Thousand USD | 0.0% |
| 2017 FY | 131.45 Thousand USD | 418.68% |
| 2016 Q1 | -406.45 Thousand USD | 2.58% |
| 2016 FY | -41.25 Thousand USD | 90.11% |
| 2016 Q3 | -183.45 Thousand USD | 36.35% |
| 2016 Q2 | -288.21 Thousand USD | 29.09% |
| 2016 Q4 | -41.25 Thousand USD | 77.51% |
| 2015 FY | -417.2 Thousand USD | -5359.41% |
| 2015 Q4 | -417.2 Thousand USD | 17.64% |
| 2015 Q1 | -108.87 Thousand USD | -1324.69% |
| 2015 Q3 | -506.55 Thousand USD | -1570.41% |
| 2015 Q2 | -30.32 Thousand USD | 72.15% |
| 2014 FY | -7642.00 USD | 89.38% |
| 2014 Q2 | -21.21 Thousand USD | 45.24% |
| 2014 Q4 | -7642.00 USD | 93.57% |
| 2014 Q1 | -38.73 Thousand USD | 46.19% |
| 2014 Q3 | -118.85 Thousand USD | -460.31% |
| 2013 Q2 | -21.57 Thousand USD | 74.68% |
| 2013 FY | -71.99 Thousand USD | 58.0% |
| 2013 Q4 | -71.99 Thousand USD | -324.75% |
| 2013 Q3 | -16.94 Thousand USD | 21.44% |
| 2013 Q1 | -85.19 Thousand USD | 50.3% |
| 2012 Q1 | -725.82 Thousand USD | 18.48% |
| 2012 Q3 | -387.48 Thousand USD | -121.15% |
| 2012 FY | -171.42 Thousand USD | 80.75% |
| 2012 Q2 | -175.21 Thousand USD | 75.86% |
| 2012 Q4 | -171.42 Thousand USD | 55.76% |
| 2011 Q3 | -1.52 Million USD | 27.8% |
| 2011 Q1 | -2.83 Million USD | 14.1% |
| 2011 Q2 | -2.1 Million USD | 25.52% |
| 2011 FY | -890.32 Thousand USD | 72.98% |
| 2011 Q4 | -890.32 Thousand USD | 41.51% |
| 2010 Q1 | -3.87 Million USD | -66.5% |
| 2010 Q3 | -4.6 Million USD | -86.87% |
| 2010 Q4 | -3.29 Million USD | 28.43% |
| 2010 FY | -3.29 Million USD | -41.51% |
| 2010 Q2 | -2.46 Million USD | 36.45% |
| 2009 Q3 | -169.55 Thousand USD | -44.98% |
| 2009 Q1 | -310.37 Thousand USD | 4.76% |
| 2009 FY | -2.32 Million USD | -614.64% |
| 2009 Q4 | -2.32 Million USD | -1273.58% |
| 2009 Q2 | -116.94 Thousand USD | 62.32% |
| 2008 FY | -325.88 Thousand USD | 80.23% |
| 2008 Q2 | -818.49 Thousand USD | 37.8% |
| 2008 Q3 | -570.16 Thousand USD | 30.34% |
| 2008 Q1 | -1.31 Million USD | 20.18% |
| 2008 Q4 | -325.88 Thousand USD | 42.84% |
| 2007 Q3 | -2.03 Million USD | -227.15% |
| 2007 FY | -1.64 Million USD | -293.59% |
| 2007 Q4 | -1.64 Million USD | 18.91% |
| 2007 Q2 | 1.59 Million USD | 31.29% |
| 2007 Q1 | 1.21 Million USD | 43.02% |
| 2006 Q2 | 743.47 Thousand USD | 51.29% |
| 2006 FY | 851.52 Thousand USD | 188.49% |
| 2006 Q3 | 1.17 Million USD | 57.37% |
| 2006 Q4 | 851.52 Thousand USD | -27.22% |
| 2006 Q1 | 491.42 Thousand USD | 66.49% |
| 2005 Q1 | 805.57 Thousand USD | -56.11% |
| 2005 Q3 | -2386.00 USD | -100.25% |
| 2005 FY | 295.16 Thousand USD | -83.92% |
| 2005 Q4 | 295.16 Thousand USD | 12470.79% |
| 2005 Q2 | 966.63 Thousand USD | 19.99% |
| 2004 Q1 | 352.05 Thousand USD | 559.67% |
| 2004 FY | 1.83 Million USD | 333.48% |
| 2004 Q4 | 1.83 Million USD | -9.38% |
| 2004 Q3 | 2.02 Million USD | 62667.78% |
| 2004 Q2 | -3237.00 USD | -100.92% |
| 2003 Q3 | -20.42 Thousand USD | -109.06% |
| 2003 Q4 | -76.58 Thousand USD | -274.98% |
| 2003 FY | 423.41 Thousand USD | 536063.29% |
| 2003 Q1 | -8854.00 USD | -11107.59% |
| 2003 Q2 | -9770.00 USD | -10.35% |
| 2002 FY | -79.00 USD | -103.44% |
| 2002 Q3 | -20.00 USD | 95.58% |
| 2002 Q2 | -452.00 USD | 86.25% |
| 2002 Q1 | -3288.00 USD | -243.33% |
| 2002 Q4 | -79.00 USD | -295.0% |
| 2001 Q3 | -688.00 USD | 0.0% |
| 2001 Q4 | 2294.00 USD | 433.43% |
| 2001 FY | 2294.00 USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Achiko AG | 2.48 Million USD | 100.0% |
| Accelera Innovations, Inc | - USD | NaN% |
| Aspyra Inc. | 3.95 Million USD | 100.0% |
| Cannabis Sativa, Inc. | 206.45 Thousand USD | 100.0% |
| CompuMed, Inc. | -686.23 Thousand USD | 100.0% |
| CompuGroup Medical SE & Co. KGaA | 775.35 Million USD | 100.0% |
| Cogstate Limited | -29.45 Million USD | 100.0% |
| CareView Communications, Inc. | 19.88 Million USD | 100.0% |
| Craneware plc | 783 Thousand USD | 100.0% |
| Caduceus Software Systems Corp. | 2.38 Million USD | 100.0% |
| Certive Solutions Inc. | 5.68 Million USD | 100.0% |
| Drug Free Solution, Inc. | -12.5 Thousand USD | 100.0% |
| DATATRAK International, Inc. | 103.82 Thousand USD | 100.0% |
| Strainsforpains, Inc. | 1.93 Million USD | 100.0% |
| Healixa Inc. | 6.5 Million USD | 100.0% |
| Easy Technologies Inc. | - USD | NaN% |
| eWellness Healthcare Corporation | - USD | NaN% |
| Founders Bay Holdings | -668.66 Thousand USD | 100.0% |
| Healthcare Integrated Technologies, Inc. | 459.64 Thousand USD | 100.0% |
| H-Source Holdings Ltd. | - USD | NaN% |
| InterCare DX, Inc. | 5062.82 USD | 100.0% |
| IQ-AI Limited | -176.63 Thousand USD | 100.0% |
| Cannabiz Mobile, Inc. | 494.04 Thousand USD | 100.0% |
| Mednow Inc. | 2.11 Million USD | 100.0% |
| Galileo Life Sciences, Inc. | 17.02 Thousand USD | 100.0% |
| MediXall Group, Inc. | 2.81 Million USD | 100.0% |
| Mitesco, Inc. | 1.76 Million USD | 100.0% |
| MobileSmith, Inc. | 4.85 Million USD | 100.0% |
| NantHealth, Inc. | 265.64 Million USD | 100.0% |
| Net Medical Xpress Solutions, Inc. | 661 Thousand USD | 100.0% |
| OneLife Technologies Corp. | - USD | NaN% |
| ORHub, Inc. | 8.48 Million USD | 100.0% |
| Patient Access Solutions, Inc. | 910.34 Thousand USD | 100.0% |
| Pharma-Bio Serv, Inc. | -10.09 Million USD | 100.0% |
| PPJ Healthcare Enterprises, Inc. | 2.54 Million USD | 100.0% |
| Medical Cannabis Payment Solutions, Inc. | 857.76 Thousand USD | 100.0% |
| Renalytix Plc | 3.85 Million USD | 100.0% |
| Revium Recovery Inc. | -529 Thousand USD | 100.0% |
| RYAH Group, Inc. | - USD | NaN% |
| Carepay Inc. | -414.83 Thousand USD | 100.0% |
| Vaso Corporation | -9.28 Million USD | 100.0% |
| Vynleads, Inc. | 513.29 Thousand USD | 100.0% |